Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase EARLY_PHASE1 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Melanoma 54Skin Neoplasms 16Carcinoma, Basal Cell 10Breast Neoplasms 10Sarcoma 7Lymphoma, T-Cell, Cutaneous 6Lung Neoplasms 5Keratosis, Actinic 5Carcinoma, Renal Cell 5Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Uveal Melanoma 3Sezary Syndrome 3Mycosis Fungoides 3Lymphoma 3Kidney Neoplasms 3Intraocular Lymphoma 3Hodgkin Disease 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms, Male 3Waldenstrom Macroglobulinemia 2Small Cell Lung Carcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2

Interventions

pembrolizumab 1cemiplimab 1avelumab 1Nivolumab 1Ipilimumab 1Immune Checkpoint Inhibitors 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Motor Activity × Dermatologic × Clear all
NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡